Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Get valuable insight on select drug products and medically-relevant topics, courtesy of the pharmaceutical industry.
Boehringer Ingelheim announced that Ofev (nintedanib) capsules are now available for the treatment of idiopathic pulmonary fibrosis (IPF).
The American College of Chest Physicians (CHEST) and Canadian Thoracic Society (CTS) have developed a joint evidence-based guideline on preventing acute exacerbations of chronic obstructive pulmonary disease (COPD).
The Food and Drug Administration has approved Esbriet (pirfenidone; Genentech) and Ofev (nintedanib; Boehringer Ingelheim) for the treatment of idiopathic pulmonary fibrosis (IPF).
Cigarette smoking accounts for approximately 14 million major medical conditions that plague the lives of U.S. adults, according to a new government report.
This program defines and distinguishes asthma from COPD, discusses the impact of these conditions on ...
This series of four activities provides the tools to enable the primary care provider to ...